Symphony Robotics’ patent-pending know-how combines micro-robotic arms, real-time laptop imaginative and prescient, and AI. | Supply: Symphony Robotics
Symphony Robotics introduced Tuesday that it licensed micro-robotic arm know-how from Case Western Reserve College (CWRU).
Cleveland-based Symphony Robotics licensed CWRU’s novel, MRI-guided, magnetically actuated robotic platform. The know-how navigates non-linear trajectories, enabling exact, micro-invasive surgical procedures with real-time steerage.
The firm plans to advance the know-how that mixes micro-robotic arms, real-time laptop imaginative and prescient, and state-of-the-art AI. Its preliminary focus facilities round offering neurosurgeons with enhanced capabilities for advanced microsurgical procedures. They aim mind most cancers — significantly glioblastoma multiforme (GBM) — and epilepsy.
Finally, Symphony says it hopes to scale back incision and craniotomy measurement to lower than 4mm. This may mark a tenfold discount in comparison with present medical norms. The know-how might allow prolonged, exact entry to deep-seated lesions whereas defending the encompassing tissue.
Register in the present day to avoid wasting 40% on convention passes!
The corporate constructed its ultra-maneuverable micro-robotic know-how to leverage MRI capabilities and allow real-time steerage. Its product stays investigational. This know-how relies on two proprietary developments: leveraging the magnetic capabilities of MRI methods for non-linear navigation of the micro robotic arms and enabling real-time steerage with MRI’s excessive decision imaging.
Symphony Robotics says it’s getting ready for nationwide testing in collaboration with main accomplice hospitals. This product shouldn’t be accessible for medical use and has not been cleared to be used by the US FDA.
Symphony targets GBM
GBM is among the many most aggressive and difficult mind cancers to deal with, the corporate says. Current surgical strategies, resembling craniotomies, are extremely invasive, requiring massive cranium openings and posing important dangers. These embrace trauma to wholesome mind tissue and delays in follow-up therapies resembling radiation, chemotherapy, or drug supply.
Different strategies resembling laser ablation solely assist a restricted and partial therapy choice. Symphony Robotics’ versatile, non-linear micro robotic arm goals to allow prolonged and exact entry to deep-seated lesions whereas defending surrounding eloquent tissue. This has the potential to enhance outcomes and high quality of life for GBM sufferers.
“Our know-how will introduce unprecedented developments in neurosurgery,” stated Mordechai (Moty) Avisar, Symphony Robotics founder and CEO. “The potential to boost surgical precision and enhance affected person outcomes is actually groundbreaking. Neurosurgeons will be capable of carry out extremely focused procedures on deep-seated pathologies by way of considerably smaller surgical openings—right down to the micro degree—whereas navigating advanced, geometrically dispersed pathologies with larger security and accuracy.”
Editor’s Word: This text was syndicated from The Robotic Report’s sibling web site MassDevice.
